Dr. Martin B. Brenner

Dr. Martin B. Brenner

Chief Executive Officer and Chief Scientific OfficeratiBio· In proxies 2022–2025

Pay in FY2025+19% from the year before · iBio stock -63.8% the same year

Dr. Martin B. Brenner was paid $1.5M in FY2025 (Jun), up 19%. iBio stock fell 63.8% that year.

Pay$100 in the stock at the end of FY21 → $1
Pay is from the Summary Compensation Table of each iBio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. iBioPublic company · 4 yr
    • Chief Executive Officer and Chief Scientific Officer2022 – Present · 4 yrStock in role -100%

Roles come from the proxy statements of each company.

Boards1

  • iBioDirector · 1 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?